Literature DB >> 21765009

Single-step capture and sequencing of natural DNA for detection of BRCA1 mutations.

John F Thompson1, Jeffrey G Reifenberger, Eldar Giladi, Kristen Kerouac, Jaime Gill, Erik Hansen, Avak Kahvejian, Philipp Kapranov, Travis Knope, Doron Lipson, Kathleen E Steinmann, Patrice M Milos.   

Abstract

Genetic testing for disease risk is an increasingly important component of medical care. However, testing can be expensive, which can lead to patients and physicians having limited access to the genetic information needed for medical decisions. To simplify DNA sample preparation and lower costs, we have developed a system in which any gene can be captured and sequenced directly from human genomic DNA without amplification, using no proteins or enzymes prior to sequencing. Extracted whole-genome DNA is acoustically sheared and loaded in a flow cell channel for single-molecule sequencing. Gene isolation, amplification, or ligation is not necessary. Accurate and low-cost detection of DNA sequence variants is demonstrated for the BRCA1 gene. Disease-causing mutations as well as common variants from well-characterized samples are identified. Single-molecule sequencing generates very reproducible coverage patterns, and these can be used to detect any size insertion or deletion directly, unlike PCR-based methods, which require additional assays. Because no gene isolation or amplification is required for sequencing, the exceptionally low costs of sample preparation and analysis could make genetic tests more accessible to those who wish to know their own disease susceptibility. Additionally, this approach has applications for sequencing integration sites for gene therapy vectors, transposons, retroviruses, and other mobile DNA elements in a more facile manner than possible with other methods.

Entities:  

Mesh:

Year:  2011        PMID: 21765009      PMCID: PMC3266041          DOI: 10.1101/gr.122192.111

Source DB:  PubMed          Journal:  Genome Res        ISSN: 1088-9051            Impact factor:   9.043


  24 in total

1.  Evaluation of hybridization conditions for spotted oligonucleotide-based DNA microarrays.

Authors:  Mong-Hsun Tsai; Hailing Yan; Xi Chen; G V R Chandramouli; Shuping Zhao; Deborah Coffin; C Norman Coleman; James B Mitchell; Eric Y Chuang
Journal:  Mol Biotechnol       Date:  2005-03       Impact factor: 2.695

Review 2.  Keeping up with the next generation: massively parallel sequencing in clinical diagnostics.

Authors:  John R ten Bosch; Wayne W Grody
Journal:  J Mol Diagn       Date:  2008-10-02       Impact factor: 5.568

3.  Single-molecule DNA sequencing of a viral genome.

Authors:  Timothy D Harris; Phillip R Buzby; Hazen Babcock; Eric Beer; Jayson Bowers; Ido Braslavsky; Marie Causey; Jennifer Colonell; James Dimeo; J William Efcavitch; Eldar Giladi; Jaime Gill; John Healy; Mirna Jarosz; Dan Lapen; Keith Moulton; Stephen R Quake; Kathleen Steinmann; Edward Thayer; Anastasia Tyurina; Rebecca Ward; Howard Weiss; Zheng Xie
Journal:  Science       Date:  2008-04-04       Impact factor: 47.728

4.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

Authors:  Y Miki; J Swensen; D Shattuck-Eidens; P A Futreal; K Harshman; S Tavtigian; Q Liu; C Cochran; L M Bennett; W Ding
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

5.  Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.

Authors:  Mary-Claire King; Joan H Marks; Jessica B Mandell
Journal:  Science       Date:  2003-10-24       Impact factor: 47.728

6.  What would you do if you could sequence everything?

Authors:  Avak Kahvejian; John Quackenbush; John F Thompson
Journal:  Nat Biotechnol       Date:  2008-10       Impact factor: 54.908

7.  Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.

Authors:  Tom Walsh; Silvia Casadei; Kathryn Hale Coats; Elizabeth Swisher; Sunday M Stray; Jake Higgins; Kevin C Roach; Jessica Mandell; Ming K Lee; Sona Ciernikova; Lenka Foretova; Pavel Soucek; Mary-Claire King
Journal:  JAMA       Date:  2006-03-22       Impact factor: 56.272

8.  Quantification of the yeast transcriptome by single-molecule sequencing.

Authors:  Doron Lipson; Tal Raz; Alix Kieu; Daniel R Jones; Eldar Giladi; Edward Thayer; John F Thompson; Stan Letovsky; Patrice Milos; Marie Causey
Journal:  Nat Biotechnol       Date:  2009-07-05       Impact factor: 54.908

9.  Interest in genetic testing among first-degree relatives of breast cancer patients.

Authors:  C Lerman; J Seay; A Balshem; J Audrain
Journal:  Am J Med Genet       Date:  1995-07-03

10.  Comparison of three targeted enrichment strategies on the SOLiD sequencing platform.

Authors:  Dale J Hedges; Toumy Guettouche; Shan Yang; Guney Bademci; Ashley Diaz; Ashley Andersen; William F Hulme; Sara Linker; Arpit Mehta; Yvonne J K Edwards; Gary W Beecham; Eden R Martin; Margaret A Pericak-Vance; Stephan Zuchner; Jeffery M Vance; John R Gilbert
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

View more
  10 in total

1.  An emerging toolkit for targeted cancer therapies.

Authors:  Gordon B Mills
Journal:  Genome Res       Date:  2012-02       Impact factor: 9.043

2.  Next-generation sequencing meets genetic diagnostics: development of a comprehensive workflow for the analysis of BRCA1 and BRCA2 genes.

Authors:  Lídia Feliubadaló; Adriana Lopez-Doriga; Ester Castellsagué; Jesús del Valle; Mireia Menéndez; Eva Tornero; Eva Montes; Raquel Cuesta; Carolina Gómez; Olga Campos; Marta Pineda; Sara González; Victor Moreno; Joan Brunet; Ignacio Blanco; Eduard Serra; Gabriel Capellá; Conxi Lázaro
Journal:  Eur J Hum Genet       Date:  2012-12-19       Impact factor: 4.246

3.  Genome-wide fitness profiling reveals adaptations required by Haemophilus in coinfection with influenza A virus in the murine lung.

Authors:  Sandy M Wong; Mariana Bernui; Hao Shen; Brian J Akerley
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-03       Impact factor: 11.205

Review 4.  Third-generation sequencing techniques and applications to drug discovery.

Authors:  Fatih Ozsolak
Journal:  Expert Opin Drug Discov       Date:  2012-02-02       Impact factor: 6.098

Review 5.  Genomic sequencing in clinical trials.

Authors:  Karen K Mestan; Leonard Ilkhanoff; Samdeep Mouli; Simon Lin
Journal:  J Transl Med       Date:  2011-12-30       Impact factor: 5.531

6.  Targeted next-generation sequencing for routine clinical screening of mutations.

Authors:  Jamie Mj Weaver; Paul Aw Edwards
Journal:  Genome Med       Date:  2011-09-12       Impact factor: 11.117

7.  Suppression of Alternative Lipooligosaccharide Glycosyltransferase Activity by UDP-Galactose Epimerase Enhances Murine Lung Infection and Evasion of Serum IgM.

Authors:  Sandy M Wong; Mary Darby Jackson; Brian J Akerley
Journal:  Front Cell Infect Microbiol       Date:  2019-05-15       Impact factor: 5.293

8.  DNA and RNA analyses in detection of genetic predisposition to cancer.

Authors:  Grzegorz Kurzawski; Dagmara Dymerska; Pablo Serrano-Fernández; Joanna Trubicka; Bartłomiej Masojć; Anna Jakubowska; Rodney J Scott
Journal:  Hered Cancer Clin Pract       Date:  2012-12-04       Impact factor: 2.857

9.  PALB2 and breast cancer: ready for clinical translation!

Authors:  Melissa C Southey; Zhi L Teo; Ingrid Winship
Journal:  Appl Clin Genet       Date:  2013-07-19

10.  Single molecule targeted sequencing for cancer gene mutation detection.

Authors:  Yan Gao; Liwei Deng; Qin Yan; Yongqian Gao; Zengding Wu; Jinsen Cai; Daorui Ji; Gailing Li; Ping Wu; Huan Jin; Luyang Zhao; Song Liu; Liangjin Ge; Michael W Deem; Jiankui He
Journal:  Sci Rep       Date:  2016-05-19       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.